Juvenile Dermatomyositis

Overview

This is a retrospective descriptive cross-sectional and observational multicenter clinical and progressive study of juvenile dermatomyositis. The aim is to determine the clinical, paraclinical, and evolutive characteristics and therapeutic modalities from a series of juvenile dermatomyositis identified in Alsace between 2000 to 2015.

Full Title of Study: “Retrospective Descriptive Study of Juvenile Dermatomyositis in Alsace”

Study Type

• Study Type: Observational
• Study Design
  • Time Perspective: Retrospective
• Study Primary Completion Date: January 2019

Clinical Trial Outcome Measures

Primary Measures

• Study of clinical characteristics of juvenile dermatomyositis
  • Time Frame: The period from from January 1st, 2000 to December 31st, 2015 will be examined

Participating in This Clinical Trial

Inclusion Criteria

• Age under 16 years – Have a dermatomyositis according to the diagnostic criteria of Bohan and Peter of 1975 Exclusion Criteria:

• Refusal to participate in the study

Gender Eligibility: All

Minimum Age: 1 Day

Maximum Age: 16 Years

Investigator Details

• Lead Sponsor
  • University Hospital, Strasbourg, France
• Provider of Information About this Clinical Study
  • Sponsor
• Overall Contact(s)
  • Dan LIPSKER, MD, PhD, 33.3.88.11.61.79, dan.lipsker@chru-strasbourg.fr